Icarus Medical announced that it has closed an oversubscribed $7.2 million Series A funding round to accelerate commercialization and innovation across its orthopedic bracing technology platform.
The Charlottesville, Virginia-based med-tech company originally targeted $5 million for the round, but closed at $7.2 million due to investor interest in its technology, market momentum, and long-term growth strategy.
Investors participating in the round included Riptide Ventures, OSF Ventures, CU Healthcare Innovation Fund, Highpoint Ventures, MedTech Connect, Neovate Capital Partners, and BLU Venture Investors.
Icarus Medical said the funding will support accelerated commercialization across the U.S., continued product development, manufacturing expansion, clinical validation of current devices, and personnel development as the company increases its national presence.
The company is focused on developing orthopedic bracing technologies that combine biomechanics, software, additive manufacturing, and patient-centered design. Its products are designed to help patients stay active, improve mobility, reduce pain, and maintain function.
Icarus Medical’s technologies include the Ascender Knee Brace, which is designed for patients with patellofemoral and multicompartment knee osteoarthritis. The brace uses adjustable unloading and extension assist technology.
The company also offers the Adonis Joint Distraction Knee Brace, which uses dynamic joint distraction technology to help reduce pressure within the knee joint for patients with unicompartmental osteoarthritis.
Beyond osteoarthritis, Icarus Medical is also developing solutions for post-operative recovery, neurological conditions, and complex lower extremity mobility challenges.
The company designs and manufactures its products in Charlottesville while continuing to advance its manufacturing capabilities and create new local jobs.
Over the past year, Icarus Medical was named to the Inc. 5000 list of America’s fastest-growing private companies after achieving 1,283% three-year growth. The company was also recognized with the 2026 CBIC Startup of the Year Award by the Charlottesville Business Innovation Council.
KEY QUOTES:
“This financing represents a major milestone for Icarus Medical and validates both the clinical impact of our technology and the strength of the team we have built. We are excited to partner with investors who not only believe in our mission, but who also bring strategic insight and relationships that can help accelerate our trajectory. Healthcare innovation requires more than just great technology. It requires strong clinical alignment, operational execution, and the ability to scale. We believe this group of investors positions us extremely well for the next phase of the company.”
Dave Johnson, Founder and CEO of Icarus Medical
“Our health system’s mission is to serve all persons with the greatest care and love. As we evaluated Icarus Medical, we needed to be confident that its solutions could meaningfully improve the lives of the patients we serve. Through engagement with our clinicians, we quickly validated that conviction and received strong feedback regarding both the significant unmet need and the value of Icarus’ innovative bracing technology. Icarus is at the forefront of bracing innovation, and we are proud to support the company’s growth while helping expand access to its products across our Ministry.”
Ben Spektor, Director of Venture Investments at OSF Ventures
